Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Current Assets (2010 - 2026)

Omnicell's (OMCL) quarterly Current Assets came in at $735.4 million in Q2 2026, down 12.95% year-over-year from $844.8 million in Q2 2025, and up 1.81% quarter-over-quarter from $722.3 million in Q1 2026.

Analysis

Omnicell (OMCL) Current Assets (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Current Assets for 17 consecutive years, with $735.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Current Assets fell 12.95% year-over-year to $735.4 million in Q2 2026; TTM through Jun 2026 was $735.4 million, a 12.95% decrease from a year earlier, with the FY2025 full-year figure at $680.1 million, down 16.61% from the prior year.
  • Current Assets was $735.4 million for Q2 2026 at Omnicell, up from $722.3 million in the prior quarter.
  • Over five years, Current Assets peaked at $1.0 billion in Q3 2024 and troughed at $659.6 million in Q3 2025.
  • A 5-year average of $847.0 million and a median of $847.0 million in 2022 frame the typical range for Current Assets.
  • Across the five-year window, Current Assets gained 20.55% in 2023 and tumbled 34.77% in 2025, its largest moves.
  • Over 5 years, Current Assets stood at $881.8 million in 2022, then gained by 5.19% to $927.6 million in 2023, then declined by 12.08% to $815.5 million in 2024, then fell by 16.61% to $680.1 million in 2025, then increased by 8.13% to $735.4 million in 2026.
  • The last three Current Assets figures came in at $735.4 million (Q2 2026), $722.3 million (Q1 2026), and $680.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 24.52 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 9.54 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 24.39 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 14.42 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 7.97 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 6.82 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 6.62 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 4.09 Bn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn 4.32 Bn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn 735.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 735.39 Mn
Mar 31, 2026 722.30 Mn
Dec 31, 2025 680.07 Mn
Sep 30, 2025 659.62 Mn
Jun 30, 2025 844.78 Mn
Mar 31, 2025 839.67 Mn
Dec 31, 2024 815.49 Mn
Sep 30, 2024 1.01 Bn
Jun 30, 2024 995.67 Mn
Mar 31, 2024 989.92 Mn
Dec 31, 2023 927.57 Mn
Sep 30, 2023 913.75 Mn
Jun 30, 2023 881.36 Mn
Mar 31, 2023 934.97 Mn
Dec 31, 2022 881.81 Mn
Sep 30, 2022 849.13 Mn
Jun 30, 2022 787.77 Mn
Mar 31, 2022 775.60 Mn
Dec 31, 2021 780.70 Mn
Sep 30, 2021 888.72 Mn